Angiotensin-Converting Enzyme Inhibitors and or Receptor Blockers After Acute Kidney Injury: Rehabilitation of the Supervillains*

Department of Anesthesiology and Perioperative Medicine, University of California, San Francisco, San Francisco, CA, F-CRIN INI-CRCT Network, Nancy, France Division of Nephrology and Critical Care, Department of Medicine; and Department of Anesthesia, University of California, San Francisco, San Francisco, CA *See also p. e1185. Dr. Liu's institution received funding from National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Disease; she received funding from Biomerieux, Durect, Theravance, Quark, Potrero Med, Amgen, National Policy Forum on Critical Care and Acute Renal Failure, Baxter, Astra Zeneca, American Thoracic Society, and UpToDate; and she received support for article research from the National Institutes of Health. Dr. Legrand has disclosed that he does not have any potential conflicts of interest.